Sponsor: Aelian Biotechnology

Where: D2

Aelian Biotechnology combines CRISPR screening with single-cell sequencing, leveraging two transformative technologies to enable genetic screening for complex phenotypes. We utilize the CRISPR screening workflow to map the impact of thousands of genetic perturbations on the global transcriptome at single-cell resolution, thus effectively establishing a paradigm for next generation CRISPR screens. Our powerful approach has broad applications in identifying novel drug targets or elucidating unknown mechanisms of actions of drugs.

Fri20  Dec10:50am(80 mins)	“The Single-Cell Sequencing Revolution”
	Room: Room 11B - Workshop

Fri20  Dec12:30pm(15 mins)	Single-cell CRISPR screens in primary human T cells
	Room: Hall 1B